semaglutide dpp4 Dipeptidyl peptidase-4 inhibitor Mechanism of action of incretins

C.ElliD.et al

Safety was monitored throughout

PAD is a critical contributor to DFUs, impairing blood flow to the feet, which hinders wound healing and affects nearly half of all diabetic patients

Image Credit: rasamma / Shutterstock A recent study published in the journal Pharmacological Research reviewed evidence on the effects of glucagon-like peptide 1 (GLP-1) receptor agonists (RAs) on skeletal muscle (SM) mass, quality, and function

Research in Diabetes found that just one week of mild sleep restriction decreased insulin sensitivity by 25% in healthy adults. That means the body has to work harder to clear glucose, keeps insulin elevated, and promotes fat storage regardless of how much less someone is eating

Though its less well-known than semaglutide, tirzepatide is quickly gaining traction due to higher weight loss outcomes in clinical trials